01 6Nourianz
02 8Nouriast
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 89
2019 Revenue in Millions : 92
Growth (%) : -3
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 25
2019 Revenue in Millions : 1
Growth (%) : 2,500
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 73
2020 Revenue in Millions : 89
Growth (%) : -7
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 38
2020 Revenue in Millions : 25
Growth (%) : 73
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 60
2021 Revenue in Millions : 73
Growth (%) : -18
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 49
2021 Revenue in Millions : 38
Growth (%) : 29
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 106
2022 Revenue in Millions : 110
Growth (%) : 9
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 51
2022 Revenue in Millions : 60
Growth (%) : -5
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 45
2023 Revenue in Millions : 51
Growth (%) : -12
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 58
2023 Revenue in Millions : 55
Growth (%) : 4
